|
Status |
Public on Oct 18, 2010 |
Title |
U3A_IRF7+IKKe_20h_rep1 |
Sample type |
RNA |
|
|
Source name |
U3A cells, treated with type I IFN and transfected with IRF7 and IKKe, 20h
|
Organism |
Homo sapiens |
Characteristics |
cell line: U3A cells (fibrosarcoma), deficient in STAT1 treatment: 25 IU/ml type I IFN transfection: IRF7 + IKKe time post transfection: 20h
|
Treatment protocol |
See Schmid et. Al. JBC 2010
|
Growth protocol |
See Schmid et. Al. JBC 2010
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol
|
Label |
Cy3
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 microg total RNA
|
|
|
Hybridization protocol |
Following fragmentation, 15 microg of cRNA were hybridized for 16 hr at 45C on GeneChip Hybridization Oven 640.
|
Scan protocol |
GeneChips were scanned using the GeneChip Array Scanner 7GGeneChips were scanned using the GeneChip Array Scanner 7G
|
Description |
IRF7/IKKe_rep1
|
Data processing |
The data were analyzed with GeneChip Operating Software (GCOS) ver 1.3
|
|
|
Submission date |
Oct 18, 2010 |
Last update date |
Oct 18, 2010 |
Contact name |
Benjamin tenOever |
Organization name |
New York University
|
Department |
Microbiology
|
Lab |
tenOever lab
|
Street address |
430 East 29th Street, Room 540
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10016 |
Country |
USA |
|
|
Platform ID |
GPL571 |
Series (1) |
GSE24695 |
Transcription Factor Redundancy Ensures Induction of the Antiviral State |
|